Microsatellite analysis and susceptibility to FCZ of Candida glabrata invasive isolates in Sfax Hospital, Tunisia

References

• Manfredi R, Sabbatani S, Calza L. Recurring Candida albicans esophagitis in an HIV-infected patient undergoing long-term antiretroviral therapy, and with absent-negligible immunodeficiency. Braz J Infect Dis 2007; 11: 605–609.
   PubMedGoogle Scholar
• Diekema DJ, Pfaller MA. Nosocomial candidemia: an ounce of prevention is better than a pound of cure. Infect Control Hosp Epidemiol 2004; 25: 624–626.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Gibbs DL, . Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK antifungal surveillance program, 2001 to 2005. J Clin Microbiol 2008; 46: 842–849.
   PubMed Web of Science ®Google Scholar
• Trick WE, Fridkin SK, Edwards JR, . Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989–1999. Clin Infect Dis 2002; 35: 622–630.
   Google Scholar
• Wilson AG, Pharm D, Scott TM, . Retrospective evaluation of fluconazole for the treatment of Candida glabrata fungemia. Clin Therapeut 2005; 27: 1228–1237.
   PubMedGoogle Scholar
• Shin-ichi F, Takuma H. DNA fingerprinting patterns of Candida species using Hinf1 endonuclease. Intern J Syst Evol Microbiol 2000; 50: 1381–1389.
   PubMedGoogle Scholar
• Foulet F, Nicolas N, Eloy O, . Microsatellite marker analysis as a typing system for Candida glabrata. J Clin Microbiol 2005; 43: 4574–4579.
   PubMed Web of Science ®Google Scholar
• Hunter PR. A critical review of typing methods for Candida albicans and their applications. Crit Rev Microbiol 1991; 17: 417–434.
   PubMed Web of Science ®Google Scholar
• Makni F, Sellami A, Trabelsi H, . Evolution du spectre des levures isolées dans le CHU de Sfax – Tunisie. J Mycol Med (in press).
   Google Scholar
• Richet H, Roux P. Des Champs C, . Candidemia in French hospitals: incidence rates and characteristics. Clin Microbiol Infect 2002; 8: 405–412.
   PubMed Web of Science ®Google Scholar
• Viscoli C, Girmania C, Marinus A, . Candidemia in cancer patients: a prospective, multicenter surveillance study by the invasive fungal infection Group (IFIG) of the European Organization for research and treatment of cancer (EORTC). Clin Infect Dis 1999; 28: 1071–1979.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20: 133–163.
   PubMed Web of Science ®Google Scholar
• Nguyen MH, Peacock JE, Morris AJ, . The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 1996; 100: 617–623.
   PubMed Web of Science ®Google Scholar
• Lin MY, Carmeli Y, Zumsteg J, . Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-control study. Antimicrob Agents Chemother 2005; 49: 4555–4560.
   PubMed Web of Science ®Google Scholar
• Tumbarello M, Galdarola G, Tacconelli E, . Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infections. Antimicrob Agents Chemother 1996; 38: 691–699.
   Google Scholar
• Wingard JR, Merz WG, Rinaldi MG, . Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutrpenic bone marrow transplant patient. Antimicrob Agents Chemother 1993; 37: 1847–1849.
   PubMed Web of Science ®Google Scholar
• Bennett JE, Izumikawa K, Marr KA. Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxis. Antimicrob Agents Chemother 2004; 48: 1773–1777.
   PubMed Web of Science ®Google Scholar
• Sanguinetti M, Posteraro B, Fiorib B, . Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Antimicrob Agents Chemother 2005; 49: 668–679.
   PubMed Web of Science ®Google Scholar
• Baddley JW, Smith AM, Moser SA, Pappas PG. Trends in frequency and susceptibilities of Candida glabrata bloodstream isolates at a University Hospital. Diagn Microbiol Infect Dis 2001; 39: 199–201.
   PubMedGoogle Scholar
• Cheng MF, Yu KW, Fang RB, . Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999. Diagn Microbiol Infect Dis 2004; 48: 33–37.
   PubMedGoogle Scholar
• Pfaller MA, Messer SA, Boyken L, . Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location. J Clin Microbiol 2003; 41: 2176–2179.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Messer SA, Boyken L, . Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assement from the ARTEMIS antifungal surveillance program conducted in 2001 and 2002. J Clin Microbiol 2004; 42: 3142–3146.
   PubMed Web of Science ®Google Scholar
• Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994; 220: 751–758.
   PubMed Web of Science ®Google Scholar
• Safdar A, Chaturvedi V, Koll BS, . Prospective, multicenter surveillance study of Candida glabrata: fluconazole and itraconazole susceptibility profiles in bloodstream, invasive and colonizing strains and differences between isolates from three urban teaching hospitals in New York City. Antimicrob Agents Chemother 2002; 46: 3268–3272.
   PubMed Web of Science ®Google Scholar
• Metzgar D, Van belkum A, Field D, Haubrich R, Wills C. Random amplification of polymorphic DNA and microsatellite genotyping of pre- and post-treatment isolates of Candida spp. from Human Immunodeficiency Virus-infected patients on different fluconazole regimens. J Clin Microbiol 1998; 36: 2308–2313.
   PubMed Web of Science ®Google Scholar
• Shin JH, Chae MJ, Song JW, . Changes in karyotype and azole susceptibility of sequential bloodstream isolates from patients with Candida glabrata candidemia. J Clin Microbiol 2007; 45: 2385–2391.
   PubMed Web of Science ®Google Scholar
• Schweitzer KJ, Livingston DM. Destabilization of CAG trinucleotide repeat tracts by mismatch repair mutations in yeast. Hum Mol Genet 1997; 6: 349–355.
   PubMed Web of Science ®Google Scholar
• Miret JJ, Pessoa-Brandao L, Lahue RS. Instability of CAG and CTG trinucleotide repeats in Saccharomyces cerevisiae. Mol Cell Biol 1997; 17: 3382–3387.
   PubMedGoogle Scholar
• De Meeus T, Renaud F, Mouveroux E, . Genetic structure of Candida glabrata populations in AIDS and non-AIDS patients. J Clin Microbiol 2002; 40: 2199–2206.
   PubMedGoogle Scholar
• Dodgson AR, Pujol C, Denning DW, Soll DR, Fox AJ. Multilocus sequence typing of Candida glabrata reveals geographically enriched clades. J Clin Microbiol 2003; 41: 5709–5717.
   PubMed Web of Science ®Google Scholar